In addition, neutrophils, which are increased in the blood [9] and tissues [7] of COVID-19 patients, may contribute to the endothelial damage and thus the release of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, and IL-8. This evidence concerns the gene TNF and COVID-19.